1. Home
  2. SCPH

as 09-12-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

Founded: 2013 Country:
United States
United States
Employees: N/A City: BURLINGTON
Market Cap: 299.0M IPO Year: 2017
Target Price: $12.00 AVG Volume (30 days): 2.3M
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.77 EPS Growth: N/A
52 Week Low/High: $1.94 - $6.28 Next Earning Date: 11-12-2025
Revenue: $49,969,000 Revenue Growth: 107.79%
Revenue Growth (this year): 108.95% Revenue Growth (next year): 78.30%

SCPH Daily Stock ML Predictions

Share on Social Networks: